Systematic review and meta-analysis shows dapagliflozin increases hemoglobin in chronic kidney disease patients.
Common Diabetes Drug May Help Anemia in Kidney Disease
This systematic review and meta-analysis evaluated dapagliflozin in chronic kidney disease (CKD) patients with anemia. The analysis pooled d…
This study suggests a common diabetes drug could treat anemia in kidney patients without the risks of current options.
Hematocrit–albumin gap linked to sepsis risk in ICU adults in retrospective analysis
Does a simple blood number predict sepsis risk in ICU patients?
A retrospective cross-sectional analysis of 19,134 adults with first ICU admissions found that a higher hematocrit–albumin gap (HAG) was ass…
A simple blood number called the hematocrit–albumin gap predicts sepsis risk in ICU patients, with higher levels increasing infection odds b…
Total IgG Concentration Linked to Anemia in Hemodialysis Patients
Is low immunity linked to anemia in dialysis patients, or just age?
This cross-sectional study included 351 participants, comprising 179 dialysis patients and 172 healthy controls. Total immunoglobulin G (IgG…
Dialysis patients with weaker overall immune defenses are more likely to have anemia, while protection from chickenpox offers little clue ab…
Point-of-care hemoglobin meters show high sensitivity but lower specificity versus analyzer in Ghanaian study
Study finds portable anemia meters may underestimate hemoglobin levels compared to lab tests
A cross-sectional study of 100 laboratory visitors in Kumasi, Ghana compared point-of-care hemoglobin meters (Urit and Mission) to an automa…
Portable anemia meters flagged every true case but also mislabeled many healthy people as anemic, underestimating hemoglobin levels by about…
Report describes anemia prevalence among pregnant women participating in WIC program
Report describes anemia rates among pregnant women in WIC nutrition program
An observational report describes anemia prevalence among pregnant women enrolled in the WIC program in the United States. No specific preva…
A new report describes anemia rates among pregnant women in the WIC nutrition program, but offers no specific numbers or comparisons to othe…
Edoxaban 12 months superior to 3 months for VTE prevention in cancer DVT, regardless of anemia status
For cancer patients with a leg blood clot and anemia, does longer treatment work better?
In this prespecified subgroup analysis of the ONCO DVT study, 12 months of edoxaban was superior to 3 months for preventing symptomatic recu…
Cancer patients with leg clots and anemia get better protection against new clots with 12 months of edoxaban compared to just 3 months, with…